STANFORD UNIVERSITY
Engineered Treg therapy for pediatric Crohn's disease.
Engineered Treg therapy for pediatric Crohn's disease. is a funding opportunity from STANFORD UNIVERSITY, up to 427146, closing May 31, 2028.
May 31, 2028
(670d left)Overview
Summary Pediatric Crohn’s disease (CD) is a rare and chronic immune-mediated condition that is managed, but not cured, with continuous anti-inflammatory/immunosuppressive drugs. The condition leads to impaired growth, poor quality of life, and irreversible organ damage that often necessitates surgery, although…